Industry: Pharmaceuticals, Biotechnology
ARIUS Research Inc. is a biotechnology company dedicated to the discovery and development of novel anticancer monoclonal antibodies (MAbs) focused on destroying cancer cells. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRSTÔ, that rapidly identifies powerful MAbs targeting a variety of cancer indications. This antibody generation engine has enabled ARIUS to assemble a growing pipeline, which is used for commercial collaborations and in-house development. ARIUS has ongoing partnerships with key biotechnology and drug development companies. The company is listed on the TSX under the symbol “ARI”. ( www.ariusresearch.com )
ARIUS Research Inc.
55 York Street 15Th Floor
Toronto, Ontario M5J 1R7
Canada
Tel: (416) 862-2323
Fax: (416) 862-9696